Takashi Wagata
- Oncology top 10%
- Cancer-related Molecular Pathways 5
- Pancreatic and Hepatic Oncology Research 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
-
- Cancer-related gene regulation 3
- RNA modifications and cancer 2
- Pathology and Forensic Medicine top 10%
- Otorhinolaryngology top 10%
-
- Esophageal Cancer Research and Treatment 3
-
- Cancer Research and Treatments 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Yutaka ShimadaMasayuki ImamuraIchio ShibagakiKanji IshizakiMituo IkenagaTakayoshi TobeM ImamuraKimitsune Ishizaki
- Partner nations
- Japan
In The Last Decade
Takashi Wagata
13 papers receiving 891 citations
Peers
Comparison fields: 5 of 63
- Oncology 422
- Cancer Research 200
- Molecular Biology 539
- Pathology and Forensic Medicine 130
- Otorhinolaryngology 26
Countries citing papers authored by Takashi Wagata
This map shows the geographic impact of Takashi Wagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Wagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Wagata more than expected).
Fields of papers citing papers by Takashi Wagata
This network shows the impact of papers produced by Takashi Wagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Wagata. The network helps show where Takashi Wagata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takashi Wagata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 1 | |
| 2 | 2008 | 0 | |
| 3 | 2008 | 2 | |
| 4 | 2007 | 1 | |
| 5 | 1996 | 44 | |
| 6 | 1996 | 1 | |
| 7 | p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. | 1995 | 48 |
| 8 | 1994 | 4 | |
| 9 | Allelotype analysis of esophageal squamous cell carcinoma. | 1994 | 96 |
| 10 | Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. | 1993 | 136 |
| 11 | 1992 | 450 | |
| 12 | 1992 | 35 | |
| 13 | [Protein-free culture of esophageal cancer cell lines]. | 1991 | 2 |
| 14 | Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. | 1991 | 62 |
| 15 | 1990 | 17 |
About Takashi Wagata
Takashi Wagata is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 15 papers that have together received 899 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer-related gene regulation (3 papers), Esophageal Cancer Research and Treatment (3 papers), RNA modifications and cancer (2 papers), Cancer Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (422 citations), Cancer Research (200 citations) and Molecular Biology (539 citations). Takashi Wagata has collaborated with scholars based in Japan. Frequent co-authors include Yutaka Shimada, Masayuki Imamura, Ichio Shibagaki, Kanji Ishizaki, Mituo Ikenaga, Takayoshi Tobe, M Imamura, Kimitsune Ishizaki, Junya Toguchida and David W. Yandell. Their work appears in journals such as International Journal of Cancer, Cancer, Pancreas, World Journal of Gastroenterology and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.